After treatment with CAT at doses of 10–40 mg/kg, HYP levels in the lung tissues of rats with lung fibrosis and TGF-β1 levels in the serum were reduced compared to those in the BLM group (Figures 4F,G). Here, CAT is linked to pulmonary fibrosis.